Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro

Following the publication of this article, the authors noted that Fig. 1 appeared incorrectly in the journal. Essentially, the figure was reorganized but only the labels for Fig. 1B and C were switched around, with the result that Fig. 1B and C were labelled incorrectly in the paper. The corrected figure is shown here, with the figure parts for Fig. 1B and C now labelled correctly. This error was introduced into the figure during the pre-press stages. The editorial office wishes to apologize to the authors for this mistake, and we regret the inconvenience this mistake has caused. [the original article was published in the Molecular Medicine Reports 12: 7801-7805, 2015; DOI: 0.3892/mmr.2015.4352].